资讯

PharmaTimes

Imfinzi approved for NHS use in limited-stage small cell lung cancer

AstraZeneca’s Imfinzi (durvalumab) has been approved for NHS use in England and Wales for adults with limited-stage small ...
PharmaTimes

Vorasidenib approved in UK for treating IDH-mutant brain tumours

The MHRA has approved vorasidenib (Voranigo) for patients aged 12 and above with grade 2 astrocytoma or oligodendroglioma ...